Frazier Life Sciences is a biopharmaceutical venture investment firm headquartered in Palo Alto, California, with additional offices in San Diego, Boston, and Seattle. The company manages private investments across the life sciences and therapeutics sectors.
Subscribe to see Frazier Life Sciences’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
Frazier Life Sciences is a company headquartered in United States. Xcout tracks 8 named people at Frazier Life Sciences, including Gordon Empey (Partner, COO and General Counsel).
2 more named people on record for Frazier Life Sciences, with roles, board committees and tenure — see the full roster →
A few of Frazier Life Sciences's closest competitors — see the full list of competitors and alternatives →
HBM Genomics is a life sciences investment firm and venture capital fund headquartered in Palo Alto, California. The firm focuses on investing in early-stage companies within the life sciences sector.
TCG Crossover Management is a registered investment adviser based in Palo Alto, California, that manages billions in assets with a focus on life sciences and crossover funding.
venBio Partners is a healthcare-focused investment firm that provides venture capital to life-sciences companies, particularly biotechnology and biopharmaceutical businesses. It serves founders and management teams seeking capital and strategic support to develop medicines and related healthcare products.
Vivo Capital is a healthcare and life-sciences investment firm headquartered in Palo Alto, California. It invests in private and public companies across biotechnology, pharmaceuticals, medical devices, and healthcare services, serving entrepreneurs and investors through venture capital, growth equity, and related strategies.
Samsara BioCapital is a venture capital firm headquartered in Palo Alto, California, specializing in investments within the biotechnology and life sciences sectors. The firm funds innovative healthcare and life science enterprises.
MPM Capital is a life-sciences investment firm and venture capital investor focused primarily on biotechnology and therapeutics companies. It provides capital and strategic support to entrepreneurs developing innovative medicines and related technologies, serving as a partner to company founders and institutional investors.
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Something wrong or missing about Frazier Life Sciences? Suggest a correction
Post the link and the card appears automatically — each network fetches the image itself.